Bionic Sight Llc

This early-stage trial is testing a new gene therapy called BS01 for people with retinitis pigmentosa, a genetic eye disease that causes vision loss. The main goals are to check if the treatment is safe and to see if it can improve patients' ability to detect light, motion, and o…

This early-stage study is testing a one-time gene therapy injection (called BS01) for people with a severe form of dry age-related macular degeneration (AMD) that causes blind spots. The goal is to see if the treatment is safe and if it can help slow down or stop the progression …